Page last updated: 2024-08-17

1,2-dipalmitoylphosphatidylcholine and Metastase

1,2-dipalmitoylphosphatidylcholine has been researched along with Metastase in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, H; Asai, T; Dewa, T; Kato, H; Koide, H; Maeda, N; Nango, M; Oku, N; Yokota, M; Yonenaga, N1
Cossu, F; Melis, G; Rombi, G1

Other Studies

2 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Metastase

ArticleYear
Susceptibility of PTEN-positive metastatic tumors to small interfering RNA targeting the mammalian target of rapamycin.
    Nanomedicine : nanotechnology, biology, and medicine, 2015, Volume: 11, Issue:1

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Cell Proliferation; Ethylenediamines; Liposomes; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neovascularization, Pathologic; Phosphatidylethanolamines; Phosphorylation; Polyethylene Glycols; PTEN Phosphohydrolase; RNA, Small Interfering; TOR Serine-Threonine Kinases

2015
mAb-labeled liposomes in breast cancer cell targeting. Therapeutics and diagnostic use of polyspecific artificial carriers.
    Annals of the New York Academy of Sciences, 1993, Nov-30, Volume: 698

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Antibodies, Monoclonal; Brain Neoplasms; Breast Neoplasms; Drug Carriers; Female; Humans; Iodine Radioisotopes; Liposomes; Liver Neoplasms; Neoplasm Metastasis; Phosphatidylethanolamines; Radioimmunodetection; Technetium

1993